It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
It is well-established that the secondary active transporters GltTk and GltPh catalyze coupled uptake of aspartate and three sodium ions, but insight in the kinetic mechanism of transport is fragmentary. Here, we systematically measured aspartate uptake rates in proteoliposomes containing purified GltTk, and derived the rate equation for a mechanism in which two sodium ions bind before and another after aspartate. Re-analysis of existing data on GltPh using this equation allowed for determination of the turnover number (0.14 s−1), without the need for error-prone protein quantification. To overcome the complication that purified transporters may adopt right-side-out or inside-out membrane orientations upon reconstitution, thereby confounding the kinetic analysis, we employed a rapid method using synthetic nanobodies to inactivate one population. Oppositely oriented GltTk proteins showed the same transport kinetics, consistent with the use of an identical gating element on both sides of the membrane. Our work underlines the value of bona fide transport experiments to reveal mechanistic features of Na+-aspartate symport that cannot be observed in detergent solution. Combined with previous pre-equilibrium binding studies, a full kinetic mechanism of structurally characterized aspartate transporters of the SLC1A family is now emerging.
Trinco et al. measure aspartate uptake rates in proteoliposomes containing purified prokaryotic Na+-coupled aspartate transporter GltTk. To overcome limitation of protein orientation, they use synthetic nanobody that blocks transporters from outside and reveal mechanistic features of Na+-aspartate symport that cannot be observed in detergent solution.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Seeger, Markus A 4
; Guskov Albert 5
; Slotboom, Dirk J 1
1 University of Groningen, Groningen Biomolecular Sciences and Biotechnology Institute, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981)
2 University of Groningen, Groningen Biomolecular Sciences and Biotechnology Institute, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981); ZoBio BV, Leiden, The Netherlands (GRID:grid.4830.f)
3 University of Groningen, Groningen Biomolecular Sciences and Biotechnology Institute, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981); University of Zurich, Institute of Medical Microbiology, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650)
4 University of Zurich, Institute of Medical Microbiology, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650)
5 University of Groningen, Groningen Biomolecular Sciences and Biotechnology Institute, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981); Moscow Institute of Physics and Technology, Dolgoprudny, Russia (GRID:grid.18763.3b) (ISNI:0000000092721542)




